Dr. Colin Lindsay   Postdoc   Phone: +33 1 42 11 51 97 E-Mail	Emma Pailler   PhD Student   Phone: +33 1 42 11 31 56 E-Mail
Marianne Oulhen   Engineer   Phone: +33 1 42 11 31 56 E-Mail	Fanny Billiot   Technician   Phone: +33 1 42 11 51 97 E-Mail

The Gustave Roussy cancer center is one of the ten world leaders in the fight against cancer. Located south of Paris on a single site GR employs 2,000 professionals working in care, research, and teaching. As an expert center in dealing with complex cancers, Gustave Roussy brings together cutting-edge medical care and human support. Gustave Roussy’s specificity is based on its therapeutic innovation, which today puts it at the forefront in very promising areas such as personalised medicine and tomorrow’s therapies (immunotherapy, DNA repair inhibitors, epigenetic modulators). A key actor on the European and international oncology scene, Gustave Roussy applies a global approach to cancer, employing multidisciplinary teams to care for each patient and define by a multidisciplinary process the best treatments for them. Top level research, conducted at the very heart of the Institute, is aimed at the integration of basic, translational and clinical approaches, so that the results can be applied as quickly as possible for the benefit of the patient.
The CTC team (translational Research Laboratory / INSERM U981) has acquired a specific scientific expertise in the field of rare circulating cell populations including CTCs, circulating endothelial cells (CECs), circulating endothelial progenitor cells (CEPs). Research activities encompass the biological and clinical significance of these cell populations in solid tumors. Since 2005, the Circulating Cell Unit has conducted numerous studies (including multicentric studies) for the clinical evaluation of CECs, CEPs and CTCs. For CTCs, different technologies (CellSearch, ISET, microfluidic device) have been evaluated and implemented with original techniques for cytomorphological, phenotypical and molecular characterization.